Women's Health
Understanding Female Hormones: Why They Matter for Your Long-Term Health
Written by Mr Stephen LingamReviewed by Dr Penny Sheehan (GMC 6056535) on
You are tired in a way that sleep does not fix. Your periods have changed, or your mood has, and nobody has given you a straight answer about why.
Hormones are often the missing piece. They govern far more than your menstrual cycle, influencing your mood, energy, bone density, heart health, metabolism and thinking. When they are balanced you barely notice them, and when they shift the effects can be felt across your whole body. Your hormonal health goes well beyond fertility and periods: it is one of the most important systems behind your long-term wellbeing.
If you would rather skip the reading, female hormone profiling is available as a standalone blood test or within our women's health screening packages from £495.
The key players
Oestrogen
Oestrogen is often called the primary female sex hormone, though its reach goes well beyond reproduction. It regulates the menstrual cycle, supports bone density, protects cardiovascular health, maintains skin elasticity, and affects mood and cognitive function.
Fluctuating oestrogen can cause irregular periods, hot flushes, vaginal dryness and mood changes, and over time a higher risk of osteoporosis and cardiovascular disease. High oestrogen relative to progesterone (oestrogen dominance) can cause heavy periods, breast tenderness and bloating, and may increase certain health risks.
Progesterone
Progesterone works alongside oestrogen to regulate the menstrual cycle. It prepares the uterine lining for pregnancy and helps maintain early pregnancy. Outside reproduction, it has a calming effect on the nervous system and supports sleep.
Low progesterone is linked with irregular cycles, premenstrual symptoms, difficulty sleeping and early pregnancy loss. It often declines before oestrogen in the approach to menopause, which contributes to perimenopausal symptoms.
Follicle-stimulating hormone (FSH)
FSH is made by the pituitary gland and stimulates the ovaries to develop follicles, which contain eggs. Levels move through the menstrual cycle, rising at the start to trigger follicle development.
Raised FSH, particularly early in the cycle (the early follicular phase), can point to diminishing ovarian reserve. Persistently high FSH is one of the markers used to confirm menopause.
Luteinising hormone (LH)
LH triggers ovulation. A surge mid-cycle causes the dominant follicle to release an egg. Testing LH can help pin down ovulation timing and, together with FSH, assess ovarian function.
A raised LH to FSH ratio may suggest polycystic ovary syndrome (PCOS).
Prolactin
Prolactin is best known for stimulating breast milk production, and it also plays a part in menstrual regulation. Raised prolactin outside pregnancy and breastfeeding can suppress ovulation, cause irregular or absent periods, and sometimes cause breast discharge.
High prolactin may point to a pituitary adenoma, which is usually benign, or be a side effect of certain medications.
Testosterone
Women produce testosterone too, in smaller amounts than men. It contributes to libido, energy, muscle mass and bone strength.
Low testosterone can cause fatigue, reduced sex drive and low mood. Raised testosterone, often seen in PCOS, can cause acne, excess facial or body hair, and irregular periods.
Why hormone testing matters
Investigating symptoms
Hormone testing can help find the cause if you have irregular periods, heavy bleeding, persistent fatigue, unexplained weight changes, mood changes, difficulty conceiving or symptoms that suggest perimenopause.
Symptoms on their own are often non-specific. A blood test gives objective data that guides diagnosis and treatment.
Assessing fertility
For women planning pregnancy, hormone testing can assess ovarian reserve and identify conditions that might affect conception. FSH, LH, oestradiol and anti-Müllerian hormone (AMH) are commonly measured in fertility assessments.
Confirming perimenopause and menopause
Menopause is often diagnosed clinically, from symptoms and age. Hormone testing helps when symptoms are ambiguous, when menopause comes early (before 45), or when treatment decisions depend on confirming hormonal status.
Raised FSH with low oestradiol, alongside irregular periods, typically indicates perimenopause or menopause.
Monitoring hormone therapy
Women on hormone replacement therapy (HRT) or hormonal contraception may benefit from periodic testing to check their levels are where they should be and to pick up any imbalance.
When to test
Hormone levels move through the menstrual cycle, so timing matters.
For general hormone profiling, testing is usually best on day 2 or 3 of your cycle, where day 1 is the first day of your period. This captures baseline levels before the shifts of ovulation.
If you are checking ovulation, a progesterone test on day 21 (or 7 days after suspected ovulation) can confirm whether it has happened.
If your periods are irregular or absent, you can test at any time, and your doctor will read the result with that in mind.
Hormones and long-term health
The hormonal changes of perimenopause and menopause reach well beyond reproduction, with real implications for long-term health.
Bone health
Oestrogen protects bone density. After menopause, falling oestrogen speeds up bone loss and raises the risk of osteoporosis and fractures. That is why bone density screening (DEXA scanning) is often recommended for postmenopausal women.
Our Advanced and Elite women's packages include DEXA scanning where clinically indicated.
Cardiovascular health
Before menopause, women have lower rates of heart disease than men, and after menopause that advantage disappears. Oestrogen protects blood vessels and cholesterol profiles, and that protection fades as levels fall.
Cardiovascular risk assessment, including lipid profiling and blood pressure monitoring, matters more and more from midlife onwards.
Metabolic health
Hormonal changes can affect metabolism, body composition and insulin sensitivity. Many women notice weight changes during perimenopause with no change in diet or exercise.
Screening for diabetes (HbA1c, fasting glucose) and other metabolic markers helps pick up problems early.
Cognitive health
Research into oestrogen and brain health is growing. Some women report cognitive changes during perimenopause, often described as brain fog or difficulty concentrating.
The long-term picture is still being studied. Keeping your metabolic and cardiovascular health in good shape appears to help protect cognitive function.
What we measure
Our female hormone profile includes:
- LH (luteinising hormone)
- FSH (follicle-stimulating hormone)
- Prolactin
- Oestradiol
For a fuller assessment, our Advanced women's screen adds thyroid function and vitamin D. Our Elite package includes a consultation with our consultant gynaecologist, Dr Hikmat Naoum, along with transvaginal ultrasound and cervical screening.
The Ultimate women's package includes an extended hormone profile with testosterone, SHBG and free androgen index, alongside full body MRI and ovarian tumour markers (CA-125, HE4 and ROMA scoring).
Taking action
Hormone testing is a starting point. Results need to be read in context, and where something is abnormal, the right follow-up arranged.
If testing shows perimenopause or menopause, options include lifestyle changes, HRT and ongoing monitoring. If results suggest PCOS, thyroid problems or another condition, specific treatment can begin.
For a specialist discussion of menopause symptoms and treatment, see the menopause consultation at Gynae Clinic.
Your results give you information, and what you do with it is what shapes your long-term health.
Book your assessment
Come and see us if your cycle, mood, energy or sleep has changed and you want a clear answer. For complex hormonal concerns or symptoms that need specialist input, consultations with our Consultant Gynaecologist, Dr Hikmat Naoum, are available.
Call 020 7183 7056 or book online at healthscreening.clinic.
References
- NHS. Menopause. Available at: https://www.nhs.uk/conditions/menopause/
- Royal College of Obstetricians and Gynaecologists (RCOG). Management of Premenstrual Syndrome. Green-top Guideline No. 48. 2016.
- National Institute for Health and Care Excellence (NICE). Menopause: diagnosis and management. NICE guideline NG23. 2015 (updated 2019). Available at: https://www.nice.org.uk/guidance/ng23
- British Menopause Society. Menopause and long-term health. Available at: https://thebms.org.uk/publications/tools-for-clinicians/
Related screening

Stephen Lingam
Managing Director
Managing Director of Medical Express Clinic and the Health Screening Clinic since 1984. Over 40 years of operational experience in private healthcare on Harley Street, overseeing patient care, clinical standards, and service delivery.

Dr Penny Sheehan
MBBS, MRCGP
General Practitioner
GMC: 6056535
Specialising in women's health, hormonal balance, and menopause management within screening contexts.
Last reviewed: 25/09/2026